The biochemical origin of pain - Proposing a new law of pain: The origin of all pain is inflammation and the inflammatory response. Part 1 of 3 - A unifying law of pain

Medical Hypotheses

Volumn 69, Issue 1, 2007, Pages 70-82

  Omoigui, Sota ^a  

^a Division of Inflammation and Pain Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE B; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; NITRIC OXIDE; PROSTAGLANDIN; SUBSTANCE P; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CHEMICAL ANALYSIS; GATE CONTROL THEORY; INFLAMMATION; NERVE CONDUCTION; PAIN; PAIN RECEPTOR; PRIORITY JOURNAL; SENSORY NERVE; SIGNAL TRANSDUCTION; SKIN TINGLING;

ANIMALS; BIOCHEMISTRY; HUMANS; IMMUNITY, NATURAL; IMMUNOLOGIC FACTORS; INFLAMMATION; MODELS, IMMUNOLOGICAL; PAIN; SIGNAL TRANSDUCTION;

EID: 34247609748     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2006.11.028     Document Type: Article

References (73)

1. Sherrington C.S. The integrative action of the nervous system (1906), Yale University Press, New Haven (CT)
2. Livingstone W.K. Pain mechanisms (1943), Macmillan, New York
3. Online Exhibit. Pain and suffering in history - narratives of science, medicine and culture. John C. Liebeskind History of Pain Collection at the Louise M. Darling Biomedical Library, UCLA.
4. Melzack R., and Wall P.D. Pain mechanisms: a new theory. Science 150 699 (1965) 971-979
5. Melzack R. Pain: past present and future. Can J Exp Psychol 47 4 (1993) 615-629
6. Pain terms: a list with definitions and notes on usage. Recommended by the IASP subcommittee on taxonomy pain 1979;6(3):249.
7. Don Ranney. Anatomy of pain: paper presented at the Ontario inter-urban pain conference, Waterloo; 1996.
8. Boivie J. Central pain syndromes. In: Campell J.N. (Ed). Pain 1996 - an updated review (1996), IASP Press, Seattle 23-29
9. Dubner R., and Basbaum A. Spinal dorsal horn plasticity following tissue or nerve injury. In: Walls P.D., and Melzack R. (Eds). Textbook of pain. 3rd ed. (1994), Churchill Livingstone, Edinburgh 225-241 [chapter 11]
10. Jensen T.S. Mechanisms of neuropathic pain. In: Campbell J.N. (Ed). Pain - an updated review (1996), IASP Press, Seattle 7-86
11. Merskey H.M., and Bogduk N. Classification of chronic pain. 2nd ed. (1994), IASP Press, Seattle p. 211
12. Dickenson A.H. Editorial I - Gate Control Theory of pain stands the test of time. Brit J Anaesth 88 6 (2002) 755-757
13. McMahon S.B., Lewin G.R., and Wall P.D. Central hyperexcitability triggered by noxious inputs. Curr Opin Neurobiol 3 4 (1993) 602-610
14. Millan M.J. The induction of pain: an integrative review. Prog Neurobiol 57 (1999) 1-164
15. Dickenson A.H. Spinal cord pharmacology of pain. Br J Anaesth 75 (1995) 193-200
16. Suzuki R., and Dickenson A.H. Neuropathic pain: nerves bursting with excitement. Neuroreport 11 (2000) R17-R21
17. Boden S.D., Davis D.O., Dina T.S., Patronas N.J., and Wiesel S.W. Abnormal magnetic-resonance scans of the lumbar spine in asymptomatic subjects. A prospective investigation. J Bone Joint Surg Am 72 3 (1990) 403-408
18. Jensen M.C., Brant-Zawadzki M.N., Obuchowski N., Modic M.T., Malkasian D., and Ross J.S. Magnetic resonance imaging of the lumbar spine in people without back pain. N Engl J Med 331 2 (1994) 69-73
19. Boos N., Semmer N., Elfering A., Schade V., Gal I., Zanetti M., et al. Natural history of individuals with asymptomatic disc abnormalities in magnetic resonance imaging: predictors of low back pain-related medical consultation and work incapacity. Spine 25 12 (2000) 1484-1492
20. Moseley J.B., O'Malley K., Petersen N.J., Menke T.J., Brody B.A., Kuykendall D.H., et al. A controlled trial of arthroscopic surgery for osteoarthritis of the knee. N Engl J Med 347 (2002) 81-88
21. Omoigui S. The biochemical origin of pain: how a new law and new drugs have led to a medical breakthrough in the treatment of persistent pain? (2002), State-of-the-Art Technologies Publishers, Hawthorne (CA)
22. Dray A. Inflammatory mediators of pain. Br J Anaesth 75 2 (1995) 125-131
23. Goldbach-Mansky R., Lee J.M., Hoxworth J.M., Smith II D., Duray P., Schumacher Jr. R.H., et al. El-Gabalawy active synovial matrix metalloproteinase-2 is associated with radiographic erosions in patients with early synovitis. Arthritis Res 2 (2000) 145-153
24. Zimmermann M. Pathophysiological mechanisms of fibromyalgia. Clin J Pain 7 Suppl. 1 (1991) S8-S15
25. Sakaue G., Shimaoka M., Fukuoka T., Hiroi T., Inoue T., Hashimoto N., et al. NF-kappa B decoy suppresses cytokine expression and thermal hyperalgesia in a rat neuropathic pain model. Neuroreport 12 10 (2001) 2079-2084
26. Samad T.A., Moore K.A., Sapirstein A., Billet S., Allchorne A., Poole S., et al. Interleukin-1beta-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity. Nature 410 6827 (2001) 471-475
27. In: Yaksh T.L., Lynch III C., Zapol W.M., Maze M., Biebuyck J.F., and Saidman L.J. (Eds). Anesthesia: biologic foundations (1997), Lippincott, Philadelphia (PA) 685-718
28. Dickenson A.H., Stanfa L.C., Chapman V., and Yaksh T.L. Anesthesia: biologic foundations. In: Yaksh T.L., Lynch III C., Zapol W.M., Maze M., Biebuyck J.F., and Saidman L.J. (Eds) (1997), Lippincott, Philadelphia 611-624
29. Oyelese A.A., Rizzo M.A., Waxman S.G., and Kocsis J.D. Differential effects of NGF and BDNF on axotomy-induced changes in GABAA receptor-mediated conductance and sodium currents in cutaneous afferent neurons. J Neurophysiol 78 (1997) 31-42
30. Waxman S.G. The molecular pathophysiology of pain: abnormal expression of sodium channel genes and its contributions to hyperexcitability in primary sensory neurons. Pain 6 (1999) S133-S140
31. Black J.A., Langworthy K., Hinson A.W., Dibb-Hajj S.D., and Waxman S.G. NGF has opposing effects on Na+ channel III and SNS gene expression in spinal sensory neurons. NeuroReport 8 (1997) 2331-2335
32. Everill B., and Kocsis J.D. Reduction of potassium currents in identified cutaneous afferent DRG neurons after axotomy. J Neurophysiol 82 (1999) 700-708
33. Ramer M.S., and Bisby M.A. Adrenergic innervation of rat sensory ganglia following proximal or distal painful sciatic neuropathy: distinct mechanisms revealed by anti-NGF treatment. Eur J Neurosci 11 3 (1999) 837-846
34. Horai R., Saijo S., Tanioka H., et al. Development of chronic inflammatory arthropathy resembling rheumatoid arthritis in interleukin 1 receptor antagonist-deficient mice. J Exp Med 191 (2000) 313-320
35. Arend W.P. Interleukin-1 receptor antagonist. Adv Immunol 54 (1993) 167-227
36. van Lent P.L.E.M., van de Loo F.A.J., Holthuysen A.E.M., van den Bersselaar L.A.M., Vermeer H., and van den Berg W.B. Major role for interleukin 1 but not for tumor necrosis factor in early cartilage damage in immune complex arthritis in mice. J Rheumatol 22 (1995) 2250-2258
37. Gravallese E.M., and Goldring S.R. Cellular mechanisms and the role of cytokines in bone erosions in rheumatoid arthritis. Arthritis Rheum 43 (2000) 2143-2151
38. Sehgal P.B., Wang L., Rayanade R., Pan H., and Margulies L. In: Mackiewicz A., Koji A., and Sehgal P.B. (Eds). Interleukin-6-type cytokines vol. 762 (1995), New York Academy of Sciences, New York 1-14
39. Jon Wanagat E.T.K., and Ershler W.B. Molecular and cellular biology of interleukin-6 and its receptor. Front Biosci 1 (1996) d340-d357
40. Akira S., Taga T., and Kishimoto T. Interleukin-6 in biology and medicine. Adv Immunol 54 (1993) 1-78
41. Kurihara N., Bertolini D., Suda T., Akiyama Y., and Roodman G.D. IL-6 stimulates osteoclast-like multinucleated cell formation in long term human marrow cultures by inducing IL-1 release. J Immunol 144 (1990) 4226-4230
42. Tamura T., Udagawa N., Takahashi N., Miyaura C., Tanaka S., Koishihara Y., et al. Soluble interleukin-6 receptor triggers osteoclast formation by interleukin-6. Proc Natl Acad Sci USA 90 (1993) 11924-11928
43. Passeri G., Girasole G., Markus T., Abrams J.S., Manolagas S.C., and Jilka R.L. 17b-estradiol regulates IL-6 production and osteoclast development in murine calvaria cell cultures. J Bone Miner Res 6 (1991) S263
44. Girasole G., Jilka R.L., Passeri F., Boswell S., Boder G., Williams D.C., et al. 17b-Estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: a potential mechanism for the antiosteoporotic effect of estrogens. J Clin Invest 89 (1992) 883-891
45. Jilka R.L., Hangoc C., Girasole G., Passeri G., Williams D.C., Abrams J.S., et al. Increased osteoclast development after estrogen loss: mediation by interleukin-6. Science 257 (1992) 88-91
46. Miyaura C., Kusano K., Masuzawa T., Chaki O., Onoe Y., Aoyagi M., et al. Endogenous bone resorbing factors in estrogen deficiency: Cooperative effects of IL-1 and IL-6. J Bone Miner Res 10 (1995) 1365-1373
47. Black K.S., Mundy G.R., and Garrett I.R. Interleukin-6 causes hypercalcemia in vivo, and enhances the bone resorbing potency of interleukin-1 and tumor necrosis factor by two orders of magnitude in vitro. J Bone Miner Res 6 (1991) S271
48. Greenfield E.M., Shaw S.M., Gornik S.A., and Banks M.A. Adenyl cyclase and interleukin 6 are downstream effectors of parathyroid hormone resulting in stimulation of bone resorption. J Clin Invest 96 (1995) 1238-1244
49. Löwik C.W.G.M., van der Pluijm G., Bloys H., Hoekman K., Bijvoet O.L.M., Asrden L.A., et al. Parathyroid hormone (PTH) and PTH-like protein (PLP) stimulate interleukin-6 production by osteogenic cells: a possible role of interleukin-6 in osteoclastogenesis. Biochem Biophys Res Commun 162 (1989) 1546-1552
50. Ishimi Y., Miyaura C., Jin C.H., Akatsu T., Abe E., Nakamura Y., et al. IL-6 is produced by osteoblasts and induces bone resorption. J Immunol 145 (1990) 3297-3303
51. Roodman G.D., Kurihara N., Ohsaki Y., Kukita T., Hosking D., Demulder A., et al. Interleukin-6: a potential autocrine/paracrine factor in Paget's disease of Bone. J Clin Invest 89 (1992) 46-52
52. Ohsaki Y., Takahashi S., Scarcez T., Demulder A., Nishihara T., Williams R., et al. Evidence for an autocrine/paracrine role for interleukin-6 in bone resorption by giant cells from giant cell tumors of bone. Endocrinology 131 (1992) 2229-2234
53. De La Mata J., Uy H.L., Guise T.A., Story B., Boyce B.F., Mundy G.R., et al. Interleukin-6 enhances hypercalcemia and bone resorption mediated by parathyroid hormone-related protein in vivo. J Clin Invest 95 (1995) 2846-2852
54. Takaoka Y., Niwa S., and Nagai H. Interleukin-1beta induces interleukin-6 production through the production of prostaglandin E(2) in human osteoblasts, MG-63 cells. J Biochem (Tokyo) 126 3 (1999) 553-558
55. Tabibzadeh S., Kong Q.F., Babaknia A., and May L.T. Progressive rise in the expression of interleukin-6 in human endometrium during menstrual cycle is initiated during the implantation window. Mol Hum Reprod 1 (1995) 2793-2799
56. Hama T., Miyamoto M., Tsukui H., Nishio C., and Hatanaka M. Interleukin-6 as a neurotrophic factor for promoting the survival of cultured basal forebrain cholinergic neurons from postnatal rats. Neurosci Lett 104 (1989) 340-344
57. Arruda J.L., Sweitzer S., Rutkowski M.D., and DeLeo J.A. Intrathecal anti-IL-6 antibody and IgG attenuates peripheral nerve injury-induced mechanical allodynia in the rat: possible immune modulation in neuropathic pain. Brain Res 879 1-2 (2000) 216-225
58. Kotake S., Sato K., Kim K.J., Takahashi N., Udagawa N., Nakamura I., et al. Interleukin-6 and soluble interleukin-6 receptors in the synovial fluids form rheumatoid arthritis patients are responsible for osteoclast-like cell formation. J Bone Miner Res 11 (1996) 88-95
59. Houssiau F., Devoglaer J.P., Van Damme J., Nagant de Deuxchaisnes C., and Van Snick J. Interleukin 6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides. Arthritis Rheum 31 (1988) 784-788
60. Kameda H., and Takeuchi T. Osteoporosis associated with rheumatoid arthritis. Nippon Rinsho 61 2 (2003) 292-298
61. Kotani N., Kushikata T., Hashimoto H., Kimura F., Muraoka M., Yodono M., et al. Intrathecal methylprednisolone for intractable postherapetic neuralgia. N Engl J Med 343 21 (2000) 1514-1519
62. Bethea J.R., Nagashima H., Acosta M.C., Briceno C., Gomez F., Marcillo A.E., et al. Systemically administered interleukin-10 reduces tumor necrosis factor-alpha production and significantly improves functional recovery following traumatic spinal cord injury in rats. J Neurotrauma 16 10 (1999) 851-863
63. Plunkett J.A., Yu C.G., Easton J.M., Bethea J.R., and Yezierski R.P. Effects of interleukin-10 (IL-10) on pain behavior and gene expression following excitotoxic spinal cord injury in the rat. Exp Neurol 168 1 (2001) 144-154
64. Samad T.A., Moore K.A., Sapirstein A., Billet S., Allchorne A., Poole S., et al. Interleukin-1beta-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity. Nature 410 6827 (2001) 471-475 [Comment in: Nature 2001;410(6827):425, 427]
65. Kayama S., Konno S., Olmarker K., Yabuki S., and Kikuchi S. Incision of the anulus fibrosis induces nerve root morphologic, vascular, and functional changes. An experimental study. Spine 21 (1996) 2539-2543
66. Olmarker K., Rydevik B., and Nordborg C. Autologous nucleus pulposus induces neurophysiologic and histologic changes in porcine cauda equina nerve roots. Spine 18 (1993) 1425-1432
67. Olmarker K., and Myers R.R. Pathogenesis of sciatic pain: role of herniated nucleus pulposus and deformation of spinal nerve root and DRG. Pain 78 (1998) 9-105
68. Myers R.R., Wagner R., and Sorkin L.S. Hyperalgesic actions of cytokines on peripheral nerves. In: Watkins L.R., and Maier S.F. (Eds). Cyokines and pain: progress in inflammation research (1999), Birkhauser Verlag, Basal 133-158
69. Borden P., and Heller R.A. Transcriptional control of matrix metalloproteinases and the tissue inhibitors of matrix metalloproteinases. Crit Rev Eukaryot Gene Exp 7 (1997) 159-178
70. He C. Molecular mechanism of transcriptional activation of human gelatinase B by proximal promoter. Cancer Lett 106 (1996) 185-191
71. Goldbach-Mansky R., Lee J.M., Hoxworth J.M., Smith II D., Duray P., Schumacher Jr. R.H., et al. Active synovial matrix metalloproteinase-2 is associated with radiographic erosions in patients with early synovitis. Arthritis Res 2 (2000) 145-153
72. Laughlin T.M., Bethea J.R., Yezierski R.P., and Wilcox G.L. Cytokine involvement in dynorphin-induced allodynia. Pain 84 2-3 (2000) 159-167
73. Olgart L. A breakthrough in the research on pain. Survey of the synaptic network may result in new analgesics. Lakartidningen 94 48 (1997) 4461-4466